Loading data
SGMTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | — | — | 2 m USD | — |
| Research and development expense | 39.05 m USD | 38.44 m USD | 19.78 m USD | 24.92 m USD |
| Operating profit | -56.89 m USD | -54.45 m USD | -30.74 m USD | -31.06 m USD |
| Income tax expense | 0 USD | 0 USD | — | — |
| Net income (reported basis) | -51.04 m USD | -45.57 m USD | -27.88 m USD | -30.5 m USD |
| Basic earnings per share | -1.58 USD/share | -1.45 USD/share | -2.66 USD/share | -165.2 USD/share |
| Diluted earnings per share | -1.58 USD/share | -1.45 USD/share | -2.66 USD/share | -165.2 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.